Showing results (31-40 of 146) with videos related to
Sort By:
Pageof 15
Journal of Analytical Atomic Spectrometry|March 16, 2013
Speciation, formation, stability and analytical challenges of human arsenic metabolitesLucy Yehiayan, Mahesh Pattabiraman, Konstantinos Kavallieratos, et al.Chemical Research in Toxicology|March 15, 2014
Dimethylarsinothioyl glutathione as a metabolite in human multiple myeloma cell lines upon exposure to DarinaparsinLucy Yehiayan, Szabina Stice, Guangliang Liu, et al.Journal of Cell Science|March 11, 2014
Procaspase-3 regulates fibronectin secretion and influences adhesion, migration and survival independently of catalytic functionMatthew Brentnall, David B Weir, Anthony Rongvaux, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2021
Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple MyelomaBenjamin G Barwick, Vikas A Gupta, Shannon M Matulis, et al.Blood Cancer Journal|November 27, 2019
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasoneTimothy M Schmidt, Benjamin G Barwick, Nisha Joseph, et al.Nature Communications|March 8, 2020
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myelomaRicha Bajpai, Aditi Sharma, Abhinav Achreja, et al.Oncogene|July 12, 2005
Caspase-9 and effector caspases have sequential and distinct effects on mitochondriaEnrique Cepero, Anne M King, Lane M Coffey, et al.Molecular Cancer Therapeutics|February 27, 2004
R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathwaysDarrin M Beaupre, Enrique Cepero, Esther A Obeng, et al.BMC Cell Biology|July 10, 2013
Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosisMatthew Brentnall, Luis Rodriguez-Menocal, Rebeka Ladron De Guevara, et al.Cancers|October 13, 2021
Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple MyelomaJames Ackley, Miguel Armenta Ochoa, Delta Ghoshal, et al.Pageof 15